Travoprost
Travoprost is an intervention with 14 clinical trials. Currently 1 active trials ongoing. Historical success rate of 83.3%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
10
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.9%
10 of 13 finished
23.1%
3 ended early
1
trials recruiting
14
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Stop Retinal Ganglion Cell Dysfunction Study
Study of Exchange of Travoprost Intraocular Implant
Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost
Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT
Clinical Trials (14)
Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Stop Retinal Ganglion Cell Dysfunction Study
Study of Exchange of Travoprost Intraocular Implant
Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost
Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT
Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost
Effects of Anti-Glaucoma Medications on the Ocular Surface
Effect of Selective Laser Trabeculoplasty Versus Travoprost on Circardian Intraocular Pressure
Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma
The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye
24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension
Effects of Travoprost on Neovascular Glaucoma
Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
All 14 trials loaded
Drug Details
- Intervention Type
- COMBINATION PRODUCT
- Total Trials
- 14